Impact of markedly elevated serum lipoprotein(a) levels (≥100 mg/dL) on the risk of coronary heart disease
- 30 September 2007
- journal article
- research article
- Published by Elsevier BV in Metabolism
- Vol. 56 (9), 1187-1191
- https://doi.org/10.1016/j.metabol.2007.04.015
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Plasma lipoprotein(a) [Lp(a)] concentrations and cardiovascular events in the elderly: evidence from the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)Atherosclerosis, 2005
- Lipoprotein(a) and Coronary Heart DiseaseCirculation, 2000
- Evaluating Novel Cardiovascular Risk Factors: Can We Better Predict Heart Attacks?Annals of Internal Medicine, 1999
- Lipoprotein(a) as a risk factor for coronary artery diseaseThe American Journal of Cardiology, 1998
- Predictive Value of Electrophoretically Detected Lipoprotein(a) for Coronary Heart Disease and Cerebrovascular Disease in a Community-Based Cohort of 9936 Men and WomenCirculation, 1997
- Lipoprotein(a) in coronary heart disease. Is it a risk factor after all?JAMA, 1994
- Relation of serum homocysteine and lipoprotein(a) concentrations to atherosclerotic disease in a prospective Finnish population based studyAtherosclerosis, 1994
- Prediction of the severity of coronary artery disease by measurement of lipoprotein (a)Coronary Artery Disease, 1992
- Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participantsAtherosclerosis, 1991
- Lipoprotein (a). Heterogeneity and biological relevance.JCI Insight, 1990